SMI 998089 / CH0009980894
13’573.43
Pkt
43.51
Pkt
0.32 %
09:08:39
| Kurse + Charts + Realtime | Nachrichten | Listen | Info | zugeh. Wertpapiere | |
|---|---|---|---|---|---|
| Snapshot | Chart (gross) | Marktberichte | enthaltene Werte | GV-Termine | Strukturierte Produkte |
| Historisch | Chartvergleich | Analysen | Top/Flop | Dividenden | Trading-Depot |
| Realtime Liste | Realtime Chart (Indikation) | Marktkapitalisierung | |||
Kurse + Charts + Realtime
Nachrichten
Info
zugeh. Wertpapiere
Analysen zu SMI-Werten
| 12.02.26 | Novartis Buy | Deutsche Bank AG | |
| 12.02.26 | Novartis Overweight | JP Morgan Chase & Co. | |
| 11.02.26 | Zurich Insurance Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 11.02.26 | Richemont Overweight | JP Morgan Chase & Co. | |
| 10.02.26 | Richemont Outperform | Bernstein Research | |
| 10.02.26 | UBS Buy | Deutsche Bank AG | |
| 10.02.26 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 10.02.26 | UBS Outperform | RBC Capital Markets | |
| 10.02.26 | Roche Overweight | Barclays Capital | |
| 09.02.26 | Novartis Halten | DZ BANK | |
| 09.02.26 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 09.02.26 | Roche Neutral | JP Morgan Chase & Co. | |
| 09.02.26 | Roche Overweight | Barclays Capital | |
| 06.02.26 | UBS Underweight | Barclays Capital | |
| 06.02.26 | Novartis Neutral | UBS AG | |
| 06.02.26 | UBS Neutral | Goldman Sachs Group Inc. | |
| 06.02.26 | Nestlé Neutral | UBS AG | |
| 05.02.26 | UBS Kaufen | DZ BANK | |
| 05.02.26 | UBS Buy | Deutsche Bank AG | |
| 05.02.26 | Novartis Buy | Deutsche Bank AG | |
| 05.02.26 | Givaudan Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.02.26 | Givaudan Halten | DZ BANK | |
| 04.02.26 | UBS Buy | Jefferies & Company Inc. | |
| 04.02.26 | UBS Outperform | RBC Capital Markets | |
| 04.02.26 | Novartis Neutral | UBS AG | |
| 04.02.26 | Givaudan Buy | Jefferies & Company Inc. | |
| 04.02.26 | Novartis Sell | Goldman Sachs Group Inc. | |
| 04.02.26 | UBS Underweight | Barclays Capital | |
| 04.02.26 | Novartis Hold | Jefferies & Company Inc. | |
| 04.02.26 | UBS Overweight | JP Morgan Chase & Co. | |
| 04.02.26 | UBS Buy | Goldman Sachs Group Inc. | |
| 02.02.26 | Roche Hold | Deutsche Bank AG | |
| 02.02.26 | ABB Sell | Deutsche Bank AG | |
| 02.02.26 | Roche Kaufen | DZ BANK | |
| 02.02.26 | Roche Underperform | Jefferies & Company Inc. | |
| 30.01.26 | Roche Neutral | Goldman Sachs Group Inc. | |
| 30.01.26 | ABB Market-Perform | Bernstein Research | |
| 30.01.26 | Givaudan Neutral | UBS AG | |
| 30.01.26 | Roche Buy | UBS AG | |
| 30.01.26 | Swiss Re Underweight | Barclays Capital |